Læknablaðið - 15.09.1986, Qupperneq 20

198
LÆKNABLAÐIÐ
venous thrombolytic treatment in acute myocar-
dial infarction. Lancet 1986; Feb 22: 397-402.
17. Simoons ML, Serruys PW, Brand MV/D, et al.
Improved survival after early thrombolysis in acute
myocardial infarction. Lancet 1985; Sept 14:
578-81.
18. Wynne J, Green LH, Mann T, Levin D, Grossmann
W. Estimation of left ventricular volumes in man
from biplane cineangiograms filmed in oblique
projections. Am J Cardiol 1978; 41: 726-32.
19. Armitage P. Statistical Methods in Medical Re-
search. Oxford: Blackwell Scientific Publications
1971.
20. Killip T, Kimball JT. Treatment of myocardial in-
farction in a coronary care unit. A two year expe-
rience with 250 patients. Am J Cardiol 1967; 20:
457.
21. Ryan M, Lown B, Horn H. Comparison of ven-
tricular ectopic activity during 24-hour monitoring
and exercise testing in patients with coronary heart
disease. N Engl J Med 1975; 292: 224-9.
22. Lew AS, Laramee P, Cercek B. Shah PK, Ganz W.
The hypotensive effect of intravenous streptoki-
nasae in patients with acute myocardial infarction.
Circulation 1985; 72(6): 1321-6.
23. Mathey DG, Sheehan FH, Schofer J, Dodge HT.
Time From Onset of Symptoms to Thrombolytic
Therapy: A Major Determinant of Myocardial
Salvage in Patients With Acute Transmural In-
farction. J Am Coll Cardiol 1985; 6: 518-25.
24. Schwarz F, Schuler G, Katus H, et al. Intracoronary
thrombolysis in Acute Myocardial Infarction: Du-
ration of Ischemia as a Major Determinant of Late
Results After Recanalization. Am J Cardiol 1982;
50: 933-7.
25. Jennings RB, Reimer KA. Factors involved in sal-
vaging ischemic myocardium: effect of reperfusion
of arterial blood. Circulation 1977; 68: Suppl 1:
25-36.
26. Schröder R. Systemic versus intracoronary strepto-
kinase infusion in the treatment of acute myocardial
infarction. J Am Coll Cardiol 1983; 1: 1254-61.
27. Neuhaus KL, Tebbe U, Sauer G, Kostering H,
Krenzer K. High dose i.v. steptokinase infusion in
acute myocardial infarction.(Abstr). Eur Heart J
1981; 2: 144.
28. Taylor GJ, Mikell FL, Moses HW, et al. Intrave-
nous Versus Intracoronary Streptokinase Therapy
for Acute Myocardial Infarction in Community
Hospitals. Am J Cardiol 1984; 54: 256-60.
29. Schröder R, Vöhringer H, Linderer T, Biamino G,
Bruggemann T, Leitner ERV. Follow-Up After
Coronary Arterial Reperfusion with Intravenous
Streptokinase in Relation to Residual Myocardial
Infarct Artery Narrowings. Am J Cardiol 1985; 55:
313-17.
30. Harrrison DG, Fergusson DW, Collins SM. Reth-
rombosis after reperfusion with streptokinase: im-
portance of geometry of residual lesions. Circula-
tion 1984; 69(5): 991-9.
31. Ong L, Reiser P, Coromilas J, Scherr L, Morrison
J. Left Ventricular Function and Rapid Release of
Creatine Kinase MB in Acute Myocardial Infarc-
tion. N Engl J Med 1983; 309: 1-6.
32. Wackers FJ, Berger HJ, Weinberg MA, Zaret BL.
Spontaneous Changes in Left Ventricular Function
Over the First 24 Hours of Acute Myocardial In-
farction: Implications for Evaluating Early Thera-
peutic Interventions. Circulation 1982; 66(4):
748-54.
33. Lee G, Low RI, Takeda P et al. Importance of
follow-up medical and surgical approaches to pre-
vent reinfarction, reocclusion and recurrent angina
following intracoronary thrombolysis with strepto-
kinase in acute myocardial infarction. Am Heart J
1982; 104: 921-4.
34. Aldrich MS, Sherman SA, Greenberg HS. Cere-
brovascular Complications of Streptokinase Infu-
sion. JAMA 1985; 253: 1777-9.
35. Lew AS, Neer T, Rodriguez L, Geft IL, Ganz W.
Clinical failure of streptokinase due to an unsu-
spected high titer of antistreptokinase antibody. J
Am Coll Cardiol 1984; 4: 183-5.
36. McGrath KG, Zeffren B, Alexander J, Kaplan K,
Roy Patterson. Allergic reactions to streptokinase
consistent with anaphylactic or antigen-antbody
complex-mediated damage. J Allergy Clin Immunol
1985; 76: 453-7.